Teladoc crashes...AGAIN! | Why $TDOC Keeps Falling | Q2 2022 Earnings | Summary and Q&A

TL;DR

Teledoc's financial results show mixed performance with positive revenue and user growth, but significant goodwill impairments. Future growth is uncertain due to challenges in the chronic care and mental health telehealth space.

Key Insights

• 🛀 Teledoc's financial results showed positive revenue growth and improved non-GAAP earnings compared to the previous year.
• 🤝 The company experienced significant goodwill impairments due to overpayment for the Levongo deal, impacting shareholder value.
• 😨 Growth in patient visits and paid memberships, particularly in chronic care, demonstrated promising operational performance.
• 👾 Challenges lie ahead for Teledoc, including slower-than-anticipated development of chronic care deals and increased competition in the mental health telehealth space.
• 📈 Future growth and profitability depend on the company's ability to address these challenges and maintain positive trends in key financial metrics.
• 🥺 Teledoc's moat, or competitive advantage, is narrowing, leading to potential concerns about future profitability.

Transcript

Read and summarize the transcript of this video on Glasp Reader (beta).

Questions & Answers

Q: What were Teledoc's financial results for the last quarter?

Teledoc's revenue increased by 18%, beating expectations, while non-GAAP earnings showed improvement but were still negative. The company experienced significant goodwill impairments, resulting in a loss per share on a GAAP basis.

Q: How did Teledoc perform in terms of patient visits and membership growth?

Teledoc saw growth in the number of visits, both in the US and internationally. Paid memberships also exceeded guidance, with a significant increase in chronic care members.

Q: What challenges does Teledoc face in the future?

Teledoc highlighted slower-than-anticipated development of chronic care deals and a slowdown in deal closures. The company also mentioned higher customer acquisition costs and increased competition in the mental health telehealth space.

Q: What should investors watch for in Teledoc's future performance?

Investors should monitor Teledoc's chronic care numbers, better health growth, average revenue per user, and free cash flow. These factors will provide insights into the company's ability to maintain growth and manage its financials.

Summary & Key Takeaways

• Teledoc's revenue increased by 18%, beating Wall Street's expectations and falling within management's guidance range.

• The company's non-GAAP earnings showed improvement compared to the previous year, coming in ahead of estimates.

• Teledoc's operations, including patient visits and paid memberships, showed positive growth, particularly in the chronic care segment.